Risk of invasive cervical cancer in relation to management of abnormal Pap smear results

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 2, 2009, Pages 188.e1-188.e7

  Silfverdal, Lena ^a   Kemetli, Levent ^b   Andrae, Bengt ^c   Sparén, Pär ^d   Ryd, Walter ^e   Dillner, Joakim ^f   Strander, Björn ^e   Törnberg, Sven ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c GÄVLE HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

Author keywords

cervical cancer risk; histologic assessment; management of abnormal Pap smear results; population based case control study; repeated cytology

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KOILOCYTOSIS; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POPULATION; PRIORITY JOURNAL; PROTECTION; RISK REDUCTION; SWEDEN; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 67651087150     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.04.006     Document Type: Article

References (29)

1. Gustafsson L., Ponten J., Zack M., and Adami H.O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8 (1997) 755-763
2. Carmichael J.A., Jeffrey J.F., Steele H.D., and Ohlke I.D. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 148 (1984) 685-690
3. Sasieni P.D., Cuzick J., and Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer: the national coordinating network for cervical screening working group. Br J Cancer 73 (1996) 1001-1005
4. Sung H.Y., Kearney K.A., Miller M., Kinney W., Sawaya G.F., and Hiatt R.A. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88 (2000) 2283-2289
5. Andrae B., Kemetli L., Sparen P., et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100 (2008) 622-629
6. Andersson-Ellstrom A., Seidal T., Grannas M., and Hagmar B. The pap-smear history of women with invasive cervical squamous carcinoma: a case-control study from Sweden. Acta Obstet Gynecol Scand 79 (2000) 221-226
7. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., and Wilkinson E.J. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2002) 2120-2129
8. Colposcopy and Programme Management. Guidelines for National Health Service cervical screening programme. National Health Service Cervical Screening Programme publication no. 20, 2004. Available at: http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp20.pdf. Accessed Sept. 15, 2007.
9. Bentley E., Cotton S.C., Cruickshank M.E., et al. Refining the management of low-grade cervical abnormalities in the UK National Health Service and defining the potential for human papillomavirus testing: a commentary on emerging evidence. J Low Genit Tract Dis 10 (2006) 26-38
10. Rylander E., and Rådberg T. To prevent cervical, vaginal and vulvar cancer-guidelines. [in Swedish]. Report no. 34 (1997), Swedish Society of Obstetrics and Gynecology, Stockholm 67
11. Mattsson B., and Wallgren A. Completeness of the Swedish cancer register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23 (1984) 305-313
12. Bolger B.S., and Lewis B.V. A prospective study of colposcopy in women with mild dyskaryosis or koilocytosis. Br J Obstet Gynaecol 95 (1988) 1117-1119
13. Solomon D., Schiffman M., and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93 (2001) 293-299
14. Soutter W.P., Wisdom S., Brough A.K., and Monaghan J.M. Should patients with mild atypia in a cervical smear be referred for colposcopy?. Br J Obstet Gynaecol 93 (1986) 70-74
15. Giles J.A., Deery A., Crow J., and Walker P. The accuracy of repeat cytology in women with mildly dyskaryotic smears. Br J Obstet Gynaecol 96 (1989) 1067-1070
16. Soutter W.P., and Fletcher A. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ 308 (1994) 1421-1423
17. Nygard J.F., Sauer T., Skjeldestad F.E., Skare G.B., and Thoresen S.O. CIN 2/3 and cervical cancer after an ASCUS pap smear: a 7-year, prospective study of the Norwegian population-based, coordinated screening program. Acta Cytol 47 (2003) 991-1000
18. Flannelly G., Anderson D., Kitchener H.C., et al. Management of women with mild and moderate cervical dyskaryosis. BMJ 308 (1994) 1399-1403
19. Shafi M.I., Luesley D.M., Jordan J.A., Dunn J.A., Rollason T.P., and Yates M. Randomized trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynaecol 104 (1997) 590-594
20. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188 (2003) 1393-1400
21. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188 (2003) 1383-1392
22. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., et al. Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature. Cancer Treat Rev 33 (2007) 514-520
23. Melnikow J., Nuovo J., Willan A.R., Chan B.K., and Howell L.P. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92 (1998) 727-735
24. Forss A., Tishelman C., Widmark C., and Sachs L. Women's experiences of cervical cellular changes: an unintentional transition from health to liminality?. Soc Health Illn 26 (2004) 306-325
25. Kennedy A.W., Salmieri S.S., Wirth S.L., Biscotti C.V., Tuason L.J., and Travarca M.J. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 63 (1996) 14-18
26. Mohammed D.K., Lavie O., de B Lopez A., Cross P., and Monaghan J.M. A clinical review of borderline glandular cells on cervical cytology. BJOG 107 (2000) 605-609
27. Bigrigg M.A., Codling B.W., Pearson P., Read M.D., and Swingler G.R. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit: experience of low-voltage diathermy loop in 1000 patients. Lancet 336 (1990) 229-231
28. Nygard J.F., Sauer T., Nygard M., Skare G.B., and Thoresen S.O. CIN 2/3 and cervical cancer in an organized screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme. J Med Screen 11 (2004) 70-76
29. Arbyn M., Paraskevaidis E., Martin-Hirsch P., Prendiville W., and Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 99 Suppl (2005) S7-S11